Clinical Trials Directory

Trials / Completed

CompletedNCT02258061

Optimal Cardiac Resynchronization Therapy Pacing Rate

Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-ischemic Heart Failure Patients: a Randomized Crossover Pilot Trial.

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The optimal pacing rate during cardiac resynchronization therapy (CRT) is not known. Investigators investigate the impact of changing basal pacing frequencies on autonomic nerve function, cardiopulmonary exercise capacity and self-perceived quality of life (QoL).

Detailed description

This is a double-blinded randomized crossover pilot study testing two basal pacing rates: DDD-60 versus DDD-80. Each patient is paced for 2 periods of 90 days with DDD-60 and DDD-80 in a randomly sequence. Blood samples NT-proBNP plasma levels are analysed at baseline and at the end of each phase using electrochemiluminescence-immunoassay. Patients rest for 15 minutes before the samples are taken. These result are monitored by supervisory group to ensure that increase of more than 15% than baseline values result in termination of study. Investigators conduct two distinct questionnaires (Minnesota Living with Heart Failure (LIfHE) questionnaire and Medical Outcome Survey Short Form (SF-36)) A symptom limiting bicycle (Ergoline, Baden-Württemberg, Germany) exercise test is performed to measure maximum work capacity and oxygen consumption at each phase. Recordings of resting muscle sympathetic nerve activity (MSNA) are sought in all patients at both rates of pacing. All patients are studied on the same set-up in the semi-recumbent position after 30 minutes of rest. Tungsten microelectrodes (Iowa Bioengineering) are inserted into the common peroneal nerve just below the knee.

Conditions

Interventions

TypeNameDescription
PROCEDUREDDD-80Basal pacing rate set to 80-bpm. Note:Patients have already pacemaker implanted before this study.
PROCEDUREDDD-60Basal pacing rate set to 60-bpm. Note:Patients have already pacemaker implanted before this study.

Timeline

Start date
2011-08-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2014-10-07
Last updated
2014-10-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02258061. Inclusion in this directory is not an endorsement.